ClinicalTrials.Veeva

Menu
T

Texas Health Physicians Group | Cardiology & Interventional Vascular Associates

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3314814
LY3298176
Lorcaserin HCl
BELVIQ
Celecoxib
Tiotropium
sodium
Naproxen
Ibuprofen
Lanabecestat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

Trial sponsors

Boehringer Ingelheim logo
AbbVie logo
AstraZeneca logo
Eisai logo
Lilly logo
Novartis logo
Pfizer logo
T
Viatris logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems